|
HTR7P1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16640030967119E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.53239984537856E-10 |
| Normal-vs-Stage2 |
7.698300E-03 |
| Normal-vs-Stage3 |
8.55382431552698E-12 |
| Normal-vs-Stage4 |
1.63802305053196E-12 |
| Stage1-vs-Stage2 |
2.410000E-02 |
| Stage1-vs-Stage3 |
6.459500E-02 |
| Stage1-vs-Stage4 |
1.52304999999631E-05 |
| Stage2-vs-Stage3 |
3.838500E-03 |
| Stage2-vs-Stage4 |
1.175220E-04 |
| Stage3-vs-Stage4 |
1.455610E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.05689967467538E-11 |
| Normal-vs-AfricanAmerican |
3.08620000000204E-06 |
| Normal-vs-Asian |
6.09410300000945E-11 |
| Caucasian-vs-AfricanAmerican |
9.677800E-01 |
| Caucasian-vs-Asian |
4.409600E-01 |
| AfricanAmerican-vs-Asian |
7.108200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.02949998420843E-10 |
| Normal-vs-Female |
9.92279591827128E-11 |
| Male-vs-Female |
8.287200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.93970453219595E-11 |
| Normal-vs-Age(41-60Yrs) |
1.60238489144149E-12 |
| Normal-vs-Age(61-80Yrs) |
3.33000294006069E-11 |
| Normal-vs-Age(81-100Yrs) |
1.158820E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.184200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.481800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.174800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.264200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.953200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.730600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.74860004253929E-09 |
| Classical-VS-Follicular |
4.273700E-02 |
| Classical-VS-Other |
2.532000E-01 |
| Classical-VS-Normal |
4.49689951942389E-10 |
| Tall-VS-Follicular |
1.03980000165649E-08 |
| Tall-VS-Other |
4.667200E-01 |
| Tall-VS-Normal |
1.62636570877339E-12 |
| Follicular-VS-Other |
1.196610E-01 |
| Follicular-VS-Normal |
9.07879999956229E-07 |
| Other-VS-Normal |
3.56369999998662E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.73590031238291E-11 |
| Normal-vs-N1 |
1.70685687805872E-12 |
| N0-vs-N1 |
4.36600000000009E-05 |
|
|
